#EAU20 Theme Week - Poster Session 6: Management of prostate cancers – from screening to metastasis
EAU
7/25/20, 8:00 PM
Europe/Madrid GMT+2
Description
Poster Session 6
Management of prostate cancers – from screening to metastasis
Poster Session 6
Saturday 25 July
17:00 - 17:45
Location: Virtual room 1
Chairs:
C. Arsov, Düsseldorf (DE) [Declined]
Z. Culig, Innsbruck (AT) [Accepted]
G.P. Haas, Syracuse (US) [Accepted]
Presentations are 2 minutes in length, followed by 2 minutes for a live discussion.
17:00 - 17:04
51 From screening to mortality reduction: An overview of the patient journey in ERSPC Rotterdam
M.J. Roobol, Rotterdam (NL) [Accepted]
By: Roobol M.J. 1 , Remmers S. 1 , Van Slooten-Midderigh M.E. 1 , Franken-Raab C.G.A.M. 1
1Erasmus University Medical Center, Dept. of Urology, Rotterdam, The Netherlands
17:04 - 17:08
PT145 Long-term oncological outcomes following active surveillance of low risk prostate cancer: A population-based study
N. Timilshina, Toronto (CA) [Accepted]
By: Timilshina N. 1 , Finelli A. 1 , Richard P. 1 , Komisarenko M. 1 , Martin .L. 1 , Tomlinson G. 2 , Sander B. 2 , Alibhai S. 3
1Univeristy Health Network, Dept. of Surgical Oncology, Toronto, Canada, 2Univeristy Health Network, Toronto Health Economics and Technology Assessment (THETA), Toronto, Canada, 3Univeristy Health Network, Dept. of Medicine, Toronto, Canada
Notes
18/7: Upload is incorrect. PDF without sound. SR called and left voicemail
17:08 - 17:12
PT157 Association of Mediterranean diet score and disease progression among localized prostate cancer patients on active surveillance
J.R. Gregg, Houston (US) [Accepted]
By: Gregg J.R. 1 , Zhang X. 2 , Zheng J. 2 , Ward J.F. 1 , Kim J. 3 , Davis J.W. 1 , Daniel C. 2
1UT MD Anderson Cancer Center, Dept. of Urology, Houston, United States of America, 2UT MD Anderson Cancer Center, Dept. of Epidemiology, Houston, United States of America, 3Merck & Co., Dept. of Clinical Research, Kenilworth, United States of America
17:12 - 17:16
PT151 Risk factors which predict biopsy upgrading over time in active surveillance for prostate cancer
P.E. Lonergan, San Francisco (US) [Accepted]
By: Lonergan P.E. 1 , Washington S.L. 1 , Zhao S. 1 , Cowan J.E. 1 , Nguyen H.G. 1 , Shinohara K. 1 , Cooperberg M.R. 1 , Carroll P.R. 1
1University of California, Dept. of Urology, San Francisco, CA, United States of America
17:16 - 17:20
PT418 Prostate mapping for cancer diagnosis: The Madrid protocol. Transperineal prostate biopsies combining micro-ultrasound and mpMRI fusion biopsy
M.E. Rodríguez Socarrás, Madrid (ES) [Accepted]
By: Rodríguez Socarrás M.E. 1 , Gomez Rivas J.A. 1 , Cuadros V. 1 , Reinoso Elbers J. 1 , Llanes Gonzalez L. 1 , Juarez Del Dago P. 1 , Fernandez Del Alamo J. 1 , Michel Mercado I.E. 1 , Gomez Sancha F. 1
1Instituto de Cirugía Urológica Avanzada (ICUA), Dept. of Urology, Madrid, Spain
17:20 - 17:24
PT053 Impact of residual microscopial evidence of prostate cancer at second tumor resection on biochemical recurrence after radical prostatectomy
K.H. Tully, Herne (DE) [Accepted]
By: Tully K.H. 1 , Schulmeyer M. 1 , Reike M. 1 , Hanske J. 1 , Von Landenberg N. 1 , Moritz R. 1 , Brock M. 1 , Hendrik J. 2 , Von Bodman C. 1 , Noldus J. 1 , Palisaar R. 1 , Roghmann F. 1
1Marien Hospital Herne, Ruhr University Bochum, Dept. of Urology and NeuroUrology, Herne, Germany, 2Ruhr University Bochum, Institute of Pathology, Herne, Germany
Notes
18/7: Will upload slides on 19/7
17:24 - 17:28
1110 Patient-reported outcomes of neoadjuvant apalutamide (ARN-509) and radical prostatectomy in treatment of intermediate to high risk prostate cancer (NEAR) trial – a phase II trial
X.Y. Yang, Singapore (SG) [Accepted]
By: Yang X.Y. 1 , Aslim E.J. 1 , Chong T.W. 1 , Yuen J.S.P. 1 , Tay K.J. 1 , Ho H.S.S. 1 , Lee L.S. 1
1Singapore General Hospital, Dept. of Urology, Singapore, Singapore
17:28 - 17:32
692 Assessing the impact of salvage radiation therapy field after radical prostatectomy: A long-term analysis from a large multi-institutional series
N. Fossati, Milan (IT) [Accepted]
By: Fossati N. 1 , Karnes R.J. 2 , Boorjian S.A. 2 , Motterle G. 2 , Bossi A. 3 , Kumar T. 3 , Di Muzio N. 4 , Cozzarini C. 4 , Noris Chiorda B. 4 , Mazzone E. 5 , Gandaglia G. 1 , Barletta F. 1 , Scuderi S. 1 , Robesti D. 1 , Bartkowiak D. 6 , Shariat S. 7 , Goldner G. 8 , Devos G. 9 , Joniau S. 9 , Berghen C. 10 , De Meerleer G. 10 , Van Poppel H. 9 , Montorsi F. 1 , Wiegel T. 6 , Briganti A. 1
1IRCCS Ospedale San Raffaele, Dept. of Oncology, Unit of Urology, Milan, Italy, 2Mayo Clinic, Dept. of Urology, Rochester, MN, United States of America, 3Gustave Roussy Institute, Dept. of Radiation Oncology, Villejuif, France, 4IRCCS Ospedale San Raffaele, Dept. of Radiotherapy, Milan, Italy, 5IRCCS Ospedale San Raffaele, Dept. of Oncology, Unit of Urolog, Milan, Italy, 6University Hospital Ulm, Dept. of Radiation Oncology, Ulm, Germany, 7Medical University of Vienna, Dept. of Urology, Vienna, Austria, 8Medical University of Vienna, Dept. of Radiation Oncology, Vienna, Austria, 9University Hospitals Leuven, Dept. of Urology, Leuven, Belgium, 10University Hospitals Leuven, Dept. of Radiotherapy, Leuven, Belgium
17:32 - 17:36
PT090 Inhibition steroid sulfatase suppresses androgen signaling and improves response to enzalutamide
A. Gao, Sacramento (US) [Accepted]
By: Gao A. 1 , Armstrong M 1 , Liu C. 1 , Liu L. 2 , Yang J. 1 , Lou W. 1 , Li P. 3 , Evans C. 1
1University of California Davis, Dept. of Urology, Sacramento, United States of America, 2Sichuan University, Dept. of Urology, Chengdu, China, 3Ohio State University, Pharmacy, Columbus, United States of America
17:36 - 17:40
1122 CDK12 expression profile and correlation with tumor associated immune cell infiltrates in prostate cancer
M.C. Hupe, Lübeck (DE) [Accepted]
By: Hupe M.C. 1 , Offermann A. 2 , Schreiber C. 2 , Merseburger A.S. 1 , Perner S. 3
1University Hospital Schleswig-Holstein, Campus Luebeck, Dept. of Urology, Lübeck, Germany, 2University Hospital Schleswig-Holstein, Campus Luebeck, Institute of Pathology, Lübeck, Germany, 3University Hospital Schleswig-Holstein, Campus Luebeck and Research Center Borstel, Leibniz Lung Center, Institute of Pathology, Lübeck, Germany
Previous registration necessary?
NO
YES
Simultaneous translation ?
NO
YES
Will it be recorded?
NO
YES
Zoran Culig, Gabriel P. Haas
From screening to mortality reduction: An overview of the patient journey in ERSPC Rotterdam
Inglês
Speakers
M.J. Roobol, N. Timilshina, J.R. Gregg, P.E. Lonergan, M.E. Rodríguez Socarrás, K.H. Tully, X.Y. Yang, N. Fossati, A. Gao, M.C. Hupe
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.